TOKYO, March 30, 2012 - GlaxoSmithKline K.K. (President: Philippe Fauchet, Head Office: Shibuya-ku, Tokyo, hereinafter referred to as GSK) and Dainippon Sumitomo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results